Veterans with HIV/AIDS received highly active antiretroviral drugs in one daily pill were almost twice as likely to adhere to their treatment regimens as those who had to keep up with multiple doses, according to a study presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy. The risk of hospitalization was about higher among the multiple-pill group compared with patients who received a single pill.

Related Summaries